Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharmaceuticals CorpfiledCriticalBayer Pharmaceuticals Corp
Priority to DO2005000036ApriorityCriticalpatent/DOP2005000036A/en
Publication of DOP2005000036ApublicationCriticalpatent/DOP2005000036A/en
DO2005000036A2005-03-102005-03-10
DERIVATIVES OF 1,6-NAFTIRIDINE AND 1,8-NAFTIRIDINE AND ITS USE TO TREAT DIABETES AND RELATED DISORDERS
DOP2005000036A
(en)
COMPOUNDS DERIVED FROM AZAESPIRO; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND ITS USE TO PREVENT AND TREAT ANXIETY, DEPRESSIVE DISORDERS, AMONG OTHER DISEASES.
COMPOUNDS DERIVED FROM IMIDAZOPIRIMIDINE; PROCESS TO PREPARE THE COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE FOR THE PREVENTION AND / OR TREATMENT OF COGNITIVE DISORDERS.
COMPOUNDS DERIVED FROM DIOXOALCANS AND DIOXOALKENS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND ITS USE TO TREAT ASTHMA, TOS, PURITO, HYPERSENSITIVITY.
compound, pharmaceutical composition, use of the compound, and methods for treating mglur5-mediated disorders and for inhibiting activation of mglur5 receptors
COMPOUND DERIVED FROM 3- (IMIDAZOLIL) -PIRAZOLO [3,4-B] PIRIDINE; PROCEDURE FOR PREPARING SUCH COMPOUND; AND ITS USE TO TREAT INFLAMMATION, IMMUNORREGULATORY DISORDERS, AMONG OTHERS.